Found 13 matching trials
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 This is a randomized, open label, multicenter phase III trial comparing the...
Show More Location
Moores UC San Diego Cancer Center
Learn More & Join Trial
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma PHASE3 This trial will compare tisagenlecleucel to standard of care in adult parti...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma PHASE2 First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Show More Location
University Hospital of Mainz
Learn More & Join Trial
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma PHASE3 The goal of this clinical study is test how well the study drug, axicabtage...
Show More Status
Active Not Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Learn More & Join Trial
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma PHASE2 This is a research study to determine the safety and tolerability of ATLCAR...
Show More Location
Lineberger Comprehensive Cancer Center at University of North Carolina
Learn More & Join Trial
AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma PHASE1 AB-101 is an off-the shelf, allogeneic cell product made of "natural killer...
Show More Location
Artiva Clinical Trial Site
Learn More & Join Trial
Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) PHASE2 This is a two-part, Phase 2, multicenter, open-label, single arm study to e...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
DALY II USA/ MB-CART2019.1 for DLBCL PHASE2 DALY II USA is a phase II, multi-center, single arm study to evaluate the e...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma PHASE1 This is a clinical trial to evaluate the safety of combining CAR T-cell the...
Show More Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial